Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001035704-03-000412
Filing Date
2003-06-18
Accepted
2003-06-18 15:49:28
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K d06760a1e10vkza.htm 10-K/A 173527
3 EX-23.1 CONSENT OF KPMG d06760a1exv23w1.txt EX-23.1 959
4 EX-99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d06760a1exv99w1.txt EX-99.1 1294
5 EX-99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER d06760a1exv99w2.txt EX-99.2 1311
  Complete submission text file 0001035704-03-000412.txt   179135
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Filer) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-18231 | Film No.: 03748837
SIC: 2834 Pharmaceutical Preparations